A single-center trial of electrographic flow mapping and concomitant voltage mapping in sinus rhythm and atrial fibrillation (FLOW EVAL-AF)
EGF patterns varied by rhythm with AF showing lower EGFC values. EGFC correlated with bipolar voltage across rhythms and atria, suggesting its potential as an atrial myopathy marker akin to high-density voltage mapping and offering insights into atrial substrate health. Trial registration ClinicalTrials.gov Identifier: NCT06260670.
Authors
- Melissa H. Kong (ORCID: https://orcid.org/0000-0001-7140-5935)
- Marloes M. Jansen (ORCID: https://orcid.org/0000-0001-9638-4384)
- Kostiantyn Ahapov
- Nishaki Mehta (ORCID: https://orcid.org/0000-0002-3992-3609)
- Philipp Sommer (ORCID: https://orcid.org/0000-0002-3037-8704)
- Steven Castellano (ORCID: https://orcid.org/0000-0003-1772-4702)
Institutions
- Oakland University (US)
- Heart and Diabetes Center North Rhine-Westphalia (DE)
- Applied StemCell (United States) (US)
- Cortex Pharmaceuticals (United States) (US)
- Beaumont Hospital, Troy (US)
- Ruhr University Bochum (DE)
Publication Details
- Journal
- Journal of Interventional Cardiac Electrophysiology
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1007/s10840-024-01946-0
- Citations
- 4
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.61